A Business at a Glance
0 of 5 daily views used (5 remaining). Sign up free for 10 daily views, or try AAPL for a full preview.
ITEM 1. BUSINESS This information included in this Annual Report should be read in conjunction with the consolidated financial statements and related notes in “Item 8. Financial Statements and Supplemental Data” of this Annual Report. Our logo and some of our trademarks and tradenames are used in this Annual Report. This Annual Report may also include trademarks, tradenames and service marks that are the property of others. Solely for convenience, trademarks, tradenames and service marks referred to in this Annual Report may appear without the ®, ™ and SM symbols. References to our trademarks, tradenames and service marks are not intended to indicate in any way that we will not assert to the fullest extent under applicable law our rights or the rights of the applicable licensors if any, nor that respective owners to other intellectual property rights will not assert, to the fullest extent under applicable law, their rights thereto.
| Metric | TTM | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 653K | - | 1.4M | 10M | 9.9M | 17M |
| Net Income | -21M | 9.1M | - | - | -5.3M | -2.5M |
| EPS | $-7.05 | $2.48 | $-23.35 | $-6.13 | $-0.65 | $-0.33 |
| Free Cash Flow | 0 | -14M | -2.2M | -1.5M | -2.6M | -2.3M |
| ROIC | -16.2% | 11.4% | - | - | -110.9% | -29.2% |
| Gross Margin | 88.5% | - | 3.6% | 53.8% | 48.0% | 33.3% |
| Debt/Equity | 0.03 | 0.04 | 12.04 | 0.44 | 0.53 | 0.00 |
| Dividends/Share | $0.00 | $1.19 | - | - | - | - |
| Operating Income | -17M | -15M | -4.4M | -2.9M | -5.3M | -2.5M |
| Operating Margin | -2648.5% | - | -322.4% | -28.4% | -53.5% | -14.6% |
| ROE | -24.9% | 22.8% | - | - | -85.4% | -39.6% |
| Shares Outstanding | 41M | 13M | 13M | 1M | 8M | 8M |
Scienture Holdings, Inc. passes 1 of 9 quality checks, indicating weak fundamentals.
The company's 5-year average gross margin is 34.7%. Total shareholder yield (dividends) is 352.3%.
Scienture Holdings, Inc. (SCNX) has a 5-year average return on invested capital (ROIC) of -42.9%. This is below average and may indicate limited pricing power.
Scienture Holdings, Inc. (SCNX) has a market capitalization of $14M. It is classified as a small-cap stock.
Yes, Scienture Holdings, Inc. (SCNX) pays a dividend with a trailing twelve-month yield of 352.31%.
Scienture Holdings, Inc. (SCNX) operates in the Pharmaceutical Preparations industry, within the Healthcare sector.
Scienture Holdings, Inc. (SCNX) generated $-14 million in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
Scienture Holdings, Inc. (SCNX) has a debt-to-equity ratio of 0.04. This indicates a conservatively financed balance sheet.
Scienture Holdings, Inc. (SCNX) reported earnings per share (EPS) of $2.48 in its most recent fiscal year.
Scienture Holdings, Inc. (SCNX) has a return on equity (ROE) of 22.8%. This indicates the company generates strong returns for shareholders.
Scienture Holdings, Inc. (SCNX) has a 5-year average gross margin of 34.7%. This indicates decent pricing power.
The Ledger Terminal provides 12 years of financial data for Scienture Holdings, Inc. (SCNX), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
Scienture Holdings, Inc. (SCNX) has a book value per share of $6.32, based on its most recent annual SEC filing.